Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

SELL
$43.42 - $57.37 $411,534 - $543,752
-9,478 Reduced 98.19%
175 $8,000
Q4 2022

Feb 14, 2023

SELL
$38.8 - $55.46 $318,160 - $454,772
-8,200 Reduced 45.93%
9,653 $481,000
Q3 2022

Nov 14, 2022

BUY
$38.15 - $57.1 $12,513 - $18,728
328 Added 1.87%
17,853 $728,000
Q2 2022

Aug 12, 2022

BUY
$33.54 - $55.0 $305,214 - $500,500
9,100 Added 108.01%
17,525 $964,000
Q1 2022

May 13, 2022

BUY
$31.02 - $48.18 $16,285 - $25,294
525 Added 6.65%
8,425 $306,000
Q4 2021

Feb 14, 2022

BUY
$41.14 - $56.98 $325,006 - $450,142
7,900 New
7,900 $368,000

Others Institutions Holding LEGN

About Legend Biotech Corp


  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $6.7B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Caisse De Depot Et Placement Du Quebec Portfolio

Follow Caisse De Depot Et Placement Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caisse De Depot Et Placement Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Caisse De Depot Et Placement Du Quebec with notifications on news.